Outsourced Pharma App Notes & Case Studies

  1. Confirming Feeder Cells For TIL Expansion 5/28/2025

    To ensure the safety of tumor-infiltrating leukocytes (TIL) therapies, it's important to use cGMP-compliant feeder cells confirmed to be non-proliferative through competency testing.

  2. A Digital Solution Embeds Quality Into Cellular Therapeutics Production 8/14/2025

    Discover how Dendreon cut review and release time by nearly 50% while maintaining a 99% right-first-time rate, which boosts collaboration, visibility, and operational efficiency across teams.

  3. Real-Time And In-Line Raman Spectroscopy For Glycan Quality Analysis 6/14/2024

    This study details the use of in-line Raman spectroscopy to monitor mAb glycan profiles within a production bioreactor, highlighting its potential for automation and customization.

  4. Benchmarking Filtration Performance Of TFF Cassettes 5/30/2025

    Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.

  5. Project Management And Strategic Planning Services 12/20/2023

    Read about the steps that led to a progressive drug design and development organization gaining approval to begin manufacturing its new, real-time release, OSD drug in-house.

  6. QC Lab Program And Project Management 12/20/2023

    A client aimed to consolidate quality control laboratory operations into a singular facility and operate as one organization. Gain insight into the services that helped deliver the project on schedule.

  7. Standardizing Cryopreservation For Cell Therapy Supply Chains 6/3/2025

    Explore how a standardized cryopreservation process is transforming leukapheresis handling by reducing risk and improving quality across the cell therapy supply chain.

  8. Choosing The Right Tech To Optimize Processes And Reduce Costs For Therapeutic Proteins 3/25/2025

    Discover how scalable and cost-effective manufacturing solutions can optimize your biopharmaceutical production, ensuring the successful commercialization of your therapeutic protein and broader patient access.

  9. Increasing Batch Size And Reducing Cycle Times For A Biologic 8/5/2025

    JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.

  10. Formulation Development For Therapeutic Oligonucleotides 6/10/2025

    Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.